Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

Share

Kappa Bioscience AS

Closing information (x1000 EUR)

Closing information 2024/12 2023/12 2022/12
Turnover 38,500 Less Arrow 29,017 Less Arrow 27,750
Financial expenses 1,963 More Arrow 2,324 Less Arrow 2,113
Earnings before taxes 14,305 Less Arrow 10,027 Less Arrow 6,394
Total assets 60,080 Less Arrow 51,091 Less Arrow 44,743
Current assets 23,798 Less Arrow 18,819 More Arrow 20,402
Current liabilities 20,323 Less Arrow 7,762 More Arrow 13,837
Equity capital 25,002 More Arrow 26,575 Less Arrow 24,138
- share capital 128 More Arrow 135 More Arrow 144

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 41.6% More Arrow 52.0% More Arrow 53.9%
Turnover per employee
Profit as a percentage of turnover 37.2% Less Arrow 34.6% Less Arrow 23.0%
Return on assets (ROA) 27.1% Less Arrow 24.2% Less Arrow 19.0%
Current ratio 117.1% More Arrow 242.5% Less Arrow 147.4%
Return on equity (ROE) 57.2% Less Arrow 37.7% Less Arrow 26.5%
Change turnover 10,966 Less Arrow 3,031 More Arrow 5,703
Change turnover % 40% Less Arrow 12% More Arrow 26%
Chg. No. of employees
Chg. No. of employees %

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.